Sodium hyaluronate supplemented culture media as a new hMSC chondrogenic differentiation media-model for <i>in vitro/ex vivo </i>screening of potential cartilage repair therapies by Monaco, Graziana et al.
 
 
University of Birmingham
Sodium hyaluronate supplemented culture media as
a new hMSC chondrogenic differentiation media-
model for in vitro/ex vivo screening of potential
cartilage repair therapies
Monaco, Graziana ; El Haj, Alicia; Alini, Mauro ; Stoddart, Martin James
DOI:
10.3389/fbioe.2020.00243
License:
Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Monaco, G, El Haj, A, Alini, M & Stoddart, MJ 2020, 'Sodium hyaluronate supplemented culture media as a new
hMSC chondrogenic differentiation media-model for in vitro/ex vivo screening of potential cartilage repair
therapies', Frontiers in Bioengineering and Biotechnology, vol. 8, 243, pp. 1-16.
https://doi.org/10.3389/fbioe.2020.00243
Link to publication on Research at Birmingham portal
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 14. Jun. 2020
fbioe-08-00243 March 27, 2020 Time: 17:40 # 1
ORIGINAL RESEARCH
published: 31 March 2020
doi: 10.3389/fbioe.2020.00243
Edited by:
Dimitrios I. Zeugolis,
National University of Ireland Galway,
Ireland
Reviewed by:
Gunil Im,
Dongguk University Ilsan Hospital,
South Korea
Martijn van Griensven,
cBITE, MERLN Institute, Maastricht
University, Netherlands
*Correspondence:
Martin James Stoddart
martin.stoddart@aofoundation.org
Specialty section:
This article was submitted to
Tissue Engineering and Regenerative
Medicine,
a section of the journal
Frontiers in Bioengineering and
Biotechnology
Received: 15 December 2019
Accepted: 09 March 2020
Published: 31 March 2020
Citation:
Monaco G, El Haj AJ, Alini M and
Stoddart MJ (2020) Sodium
Hyaluronate Supplemented Culture
Media as a New hMSC Chondrogenic
Differentiation Media-Model
for in vitro/ex vivo Screening
of Potential Cartilage Repair
Therapies.
Front. Bioeng. Biotechnol. 8:243.
doi: 10.3389/fbioe.2020.00243
Sodium Hyaluronate Supplemented
Culture Media as a New hMSC
Chondrogenic Differentiation
Media-Model for in vitro/ex vivo
Screening of Potential Cartilage
Repair Therapies
Graziana Monaco1,2, Alicia Jennifer El Haj3, Mauro Alini1 and Martin James Stoddart1,2*
1 AO Research Institute Davos, Davos, Switzerland, 2 School of Pharmacy and Bioengineering, Faculty of Medicine and
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Surgical strategies to treat articular cartilage injury such as microfracture, expose human
bone marrow stem cells (hMSCs) to synovial fluid and its components. High molecular
weight hyaluronan (hMwt HA) is one of the most abundant bioactive macromolecules
of healthy synovial fluid (hSF) and it plays an important role in the protection of
opposing articular cartilage surfaces within the synovial joint. Although hMwt HA has
been extensively used to attempt the engineering of the cartilage tissue, its effect
as media supplement has not been established. Indeed, current media are often
simple in their composition and doesn’t recapitulate the rheological and biological
features of hSF. In addition, critical in vivo molecules that can potentially change the
chondrogenic behavior of hBMSCs to make the in vitro results more predictive of
the real in vivo outcome, are lacking. In order to be one step closer to the in vivo
physiology of hSF, a new culture media supplemented with physiological level of hMwt
HA was developed and the effect of the hMwt HA on the chondrogenesis of hMSCs
that would be present in a traumatic defect after marrow stimulation techniques,
was investigated. hBMSC-seeded fibrin-polyurethane constructs were cultured in a
serum free chondropermissive control medium (HA- TGFβ-). This medium was further
supplemented with 10 ng/mL TGFβ1 (HA- TGFβ+) or 2 mg/ml hMwt HA 1.8 MDa
(HA+ TGFβ-) or both (HA+ TGFβ+). Alternatively, 1 MDa HA was mixed with the
fibrin at 0.2 mg/ml (HASc TGFβ+). The effect of hMwt HA on hMSC differentiation
was investigated at the gene expression level by RT-qPCR and total DNA, sulfated
glycosaminoglycans and Safranin O staining were evaluated. Addition of hMwt HA to
the culture media, significantly increased the synthesis of sulfated glycosaminoglycans,
especially in the early days of chondrogenesis, and reduced the upregulation of
the hypertrophic cartilage marker collagen X. hMwt HA added inside the fibrin gel
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GRAPHICAL ABSTRACT | Bioengineered media model for hMSCs chondrogenic differentiation.
(HASc TGF+) led to the best matrix deposition. hMwt HA can be one key medium
component in a more reliable in vitro/ex vivo system to reduce in vitro artifacts, enable
more accurate pre-screening of potential cartilage repair therapies and reduce the need
for animal studies.
Keywords: hyaluronic acid, mesenchymal stem cells, chondrogenic differentiation media, glycosaminoglycan,
collagen X, hypertrophy, articular cartilage, synovial fluid
INTRODUCTION
Articular cartilage is a complex anisotropic tissue which consists
of a superficial zone, middle zone, deep zone, and calcified
zone. Each zone has a well-defined structure with characteristic
collagen fiber organization and is mainly populated by the
chondrocyte, which is responsible for extracellular matrix
maintenance (Klein et al., 2009; Stoddart et al., 2009).
Articular cartilage covers the osseous ends of articulating
diarthrosis also known as synovial joints and in this anatomical
context is in contact with Synovial fluid.
The synovial fluid (SF) of healthy joints normally functions
as a biological lubricant as well as a biochemical depot through
which nutrients and regulatory cytokines are transported.
Synovial fluid which is derived from the ultrafiltration of the
blood plasma and glycoproteins, is concentrated inside the joint
by passing through the synovium, a fibrous, highly vascularized
membrane whose internal layer macrophage-like synovial cells
(type A) and type B synoviocytes resides.
High molecular weight hyaluronan (HA), is one of the
major components of healthy SF that undergoes dynamic
regulation during cartilage damage and inflammation. It plays
an important role in the protection of opposing articular
cartilage surfaces by improving joint lubrication, but is also
involved in nutrient transport to the articular cartilage tissue, it
has an excellent osmotic buffering property to maintain water
homeostasis inside the joint, acts as pressure regulator and
thanks to its gel-like structure, prevents tissue formation in the
synovial space (McDonald and Levick, 1995; Laurent et al., 1996;
Lynch et al., 1998).
Hyaluronan is composed of a repetitive sequence disaccharide
unit which consist of 1,3-beta-D-N-acetylglucosamine and 1,4-
beta-D-glucuronic acid and possess particular features that makes
it a unique biopolymer (Jiang et al., 2006). It is produced by
specific multipass transmembrane enzymes, the HA synthases 1–
3, located on the inner surfaces of the plasma membranes (Weigel
et al., 1997; Itano and Kimata, 2002; Kogan et al., 2007) and
is continuously secreted into the joint and cleared with a half-
life of 0.5–1 day in rabbit or sheep (Brown and Laurent, 1991;
Fraser et al., 1993).
In healthy synovial fluid high molecular weight hyaluronan
can achieve a molecular mass of 6–10 mega Dalton (>106
Dalton) but when inflammation or oxidative stress occurs,
an accelerated HA degradation into smaller fragments has
been observed (Noble, 2002; Jiang et al., 2011; Fakhari and
Berkland, 2013). As such, the molecular weight of HA inside
the SF is representative of the physio-pathological condition
of the tissue. High molecular weight HA (105–107 Da) is
protective for synovial joint and articular cartilage showing
anti-inflammatory, anti-angiogenic properties, stimulation of
chondrocyte proliferation and production of cartilage matrix
and scavenging function against cellular debris and oxidizing
systems (Laurent et al., 1996; Gigante and Callegari, 2011;
Gallo et al., 2019). Conversely, low molecular weight HA
is pro-inflammatory, pro-angiogenic and immune-stimulatory
reflecting a tissue under stress as happen in rheumatoid/inflamed
joints (Jiang et al., 2011; Gallo et al., 2019).
Due to its avascular nature, partial thickness defects or
disease of articular cartilage cannot be easily accessed by stem
cells. This condition associated with low metabolic activity,
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make unsuccessful self-healing and repair (Hunziker, 2000;
Huey et al., 2012).
Microfracture treatment of articular cartilage injury is the
standard clinical practice to facilitate the access of mesenchymal
stem cells (MSCs) that reside in the bone marrow cavity of
the subchondral bone at the injured site, promoting cartilage
regeneration (Steadman et al., 2001; Kang et al., 2008; Oussedik
et al., 2015). These cells would be exposed to synovial fluid and
the HA contained within.
Human mesenchymal stem cells derived from bone marrow
(hBM MSCs) represent an attractive cell source for cartilage tissue
engineering and regenerative medicines approaches, are the best
described, the most advanced in clinical use and can differentiate
in cartilage or bone (Wakitani et al., 2002; Parekkadan and
Milwid, 2010; de Vries-van Melle et al., 2014). hBM MSCs can
be easily harvested and isolated from bone marrow aspirates with
limited donor site morbidity; in addition, following expansion
BM MSCs maintain multilineage potential (Hegewald et al., 2004;
Gardner et al., 2013). It has been shown that MSCs are able to
repair both the subchondral bone and the overlying articular
cartilage, and many studies describe how MSCs are useful in
cartilage repair after injury or disease such as osteoarthritis
(Wakitani et al., 1994; Wakitani et al., 2002).
One of the main problems associated with the chondrogenic
differentiation of hBM MSCS in vitro, is that MSC-derived
chondrocytes undergo hypertrophic differentiation that causes
the neo-formed cartilage to undergo endochondral ossification
(Johnstone et al., 1998).
HA has been extensively used as a polymer in scaffolds or
hydrogel form, alone or in combination with MSCs to produce
engineered cartilage with native tissue properties (Radice et al.,
2000; Solchaga et al., 2000; Huerta-Ángeles et al., 2018; Li et al.,
2018; Gallo et al., 2019).
Although it represents one of the most abundant
macromolecules of the synovial fluid, it has not been
extensively studied as media supplement to evaluate its
effect on chondrogenesis.
Indeed, culture media currently used to induce chondrogenic
differentiation of hMSCs are often simple in their composition
and doesn’t recapitulate the rheological and biological features of
knee joint synovial fluid (Heng et al., 2004).
In this study, we hypothesize that a chondropermissive
medium containing a physiological concentration (2 mg/ml)
of exogenous high molecular weight HA 1.8 MDa (hMwt
HA), both alone and in combination with TGFβ1, will
enhance human MSC chondrogenesis in an MSC-based
tissue engineered construct. This study also evaluated the
possibility of supplementing a fibrin:polyurethane scaffold
with 1 MDa hyaluronic acid to improve the quality of the
fibrin gel-stem cell constructs for the same purpose above.
A smaller molecular weight HA was used due to issues
relating to handling and viscosity. Both sizes function
as high molecular weight HA when considering their
biological function.
Thus, our aim is to investigate the effect of hMwt HA
supplemented in culture media, or inside the scaffold, on the
chondrogenesis of hBM MSCs.
MATERIALS AND METHODS
Poly(Ester-Urethane) Scaffolds
Preparation
Poly(ester-urethane) porous sponge (PU) were prepared by
using hexamethylene diisocyanate, poly (1-caprolactone) diol
and isosorbide diol (1,4: 3,6-dianhydro-D-sorbitol) via a salt
leaching-phase inverse technique (Gorna and Gogolewski, 2002).
By this procedure interconnected macroporosity ranging from
90 to 300 µm has been uniformly achieved within the sponge.
The PU sponge was cut by water-jet (CUTEC AG, Basel,
Switzerland) producing cylindrical scaffolds (8 mm diameter
× 4 mm height) sterilized in a cold cycle at 37◦C via
ethylene oxide process and degassed under vacuum for 6 days
before to usage.
Isolation of Human Bone Marrow
Derived MSCs
Bone marrow was obtained with full ethical approval (KEK-
ZH-NR: 2010–0444/0) and the written consent from patients
undergoing routine operations due to bone fracture.
The MSCs were isolated from three different marrow aspirates
(two female 1939 and 1992, one male 1958) using Ficoll density
separation (Sigma-Aldrich, Buchs, Switzerland) (Table 1).
Mononuclear cells were collected from the interphase and the
adherent cell fraction was seeded at a density of 50,000 cells/cm2
and left to attach for 96 hrs in alpha minimum essential medium
(αMEM) (Gibco, Carlsbad, CA, United States), 10% MSC tested
fetal bovine serum (FBS) (Pan Biotech, Aidenbach, Germany), 5
ng/ml basic fibroblast growth factor (bFGF) (Peprotech, Rocky
Hill, CN, United States) and 1% penicillin/streptomycin (Gibco).
When the majority of colonies were confluent, the cells were
passaged and seeded into fresh flasks at a cell density of
3,000 cells/cm2. The chondrogenic potential of each donor was
confirmed using standard techniques.
The hBMSCs isolated from each donor were used separately
in three independent experiments.
Scaffold Seeding and Chondrogenic
Differentiation
hMSCs at passage 3 were trypsinized, suspended in a 150
µl fibrinogen-thrombin-solution and evenly seeded at a cell
density of 5 × 106 cells/150 µl in cylindrical (8 × 4 mm)
macroporous polyurethane (PU) scaffolds. The constructs were
fed with four different media for 28 days. Control medium
was serum free basal medium containing DMEM high glucose,
supplemented with 1% ITS+, 1% Pen/Strep, 1% non-essential
TABLE 1 | Legend of the donor details investigated under static conditions.
Donor Age Sex
1 79 Female
2 60 Male
3 26 Female
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amino acid, 50 µg/ml ascorbate-2-phosphate, 5 µM ε-amino-
caproic acid (EACA), 10−7 M dexamethasone (HA- TGFβ-).
This media was further supplemented with 10 ng/mL TGF-β1
(HA- TGFβ+) or with 0.2% 1.8 MDa HA (HA+ TGFβ-) or
with both (HA+ TGFβ+). When present, TGF-β1 was only
added to the medium. Where mentioned above, the HA groups
were supplemented with 1.8 MDa HA (Stanford Chemicals)
to simulate the synovial fluid concentration under normal
conditions (2.3 mg/ml) (Fam et al., 2007). In an additional group,
1 MDa HA (ALB Technology) was added at 0.02% directly into
the PU scaffolds (HASc TGFβ+) fed with standard chondrogenic
media (HA- TGFβ+).
The culture medium was changed every second day, and
conditioned medium was collected for biochemical analysis.
Gene Expression Analysis: RNA Isolation,
cDNA Synthesis, Real Time qPCR
After 7, 14, 21, and 28 days of chondrogenic culture, constructs
were harvested, and total RNA was isolated using TRI Reagent
(MRC, Cincinnati, OH/Molecular Research Centre Inc.). Total
RNA was isolated at day 0 to assess basal gene expression levels.
TaqMan reverse transcription was then performed using 1 µg
of total RNA sample, random hexamer primers and TaqMan
reverse transcription reagents (Applied Biosystems, Carlsbad,
CA, United States).
Real-time PCR was performed using the QuantStudio 6 Flex
real-time PCR system (Applied Biosystems). A panel of human
genes associated with chondrogenic markers (COL2A1, ACAN,
Sox9), the hypertrophic marker COL10A1, osteogenic markers
(RunX2; ALP; OC), the Hyaluronan receptor CD44, hyaluronan
synthases (HAS1, HAS2, HAS3) and transforming growth factor
receptors 1 and 2 (TGFβ-R1 and TGFβ-R2) were investigated.
Primers for RPLP0, COL2A1, COL10A1, ACAN, RunX2,
and OC mRNA were synthesized by Microsynth AG (Balgach,
Switzerland) (Table 2). Primers for Sox9, ALP, CD44, HAS1,
HAS2, HAS3, TGFβ_RI, TGFβ_RII were purchased from Applied
Biosystems (Warrington, United Kingdom) (Table 3).
Relative quantification of target mRNA was determined
according to the comparative CT method with hRPLP0 as
endogenous control. In addition, the level of gene expression
for each gene was determined relative to day 0 monolayer via a
11CT comparison.
TABLE 3 | Assays on demand used for qRT-PCR.
Gene Assays on demand (ID)
Sox9 Hs00165814_m1
ALP Hs00758162_m1
CD44 Hs01075861_m1
HAS1 Hs00987418_m1
HAS2 Hs00193435_m1
HAS3 Hs00193436_m1
TGFβ_RI Hs00610320_m1
TGFβ_RII Hs00234253_m1
Sox9, SRY (sex determining region Y)-box 9 cartilage transcription factor; ALP,
alkaline phosphatase; CD44, hyaluronan receptor; HAS1, hyaluronan synthase
1; HAS2, hyaluronan synthase 2; HAS3, hyaluronan synthase 3; TGFβ_RI,
transforming growth factor β1 Receptor 1; TGFβ_RII, transforming growth factor
β1 Receptor 2.
Sulfated Glycosaminoglycans and DNA
Quantification
After 28 days of culture, constructs were digested with 1ml
proteinase K 0.5 mg/ml at 56◦C for 16 h. Total DNA content
was measured spectrofluorometrically following reaction with
Bisbenzimide Hoechst 33258 dye (Polysciences Inc., Warrington,
PA, United States) with purified calf thymus DNA as standard
(Lubio Science, Luzern, Switzerland) (Labarca and Paigen, 1980).
Sulfated glycosaminoglycans (GAG) retained within the
scaffolds was determined by a direct spectrophotometric
microassay according to the dimethylmethylene blue dye method
(Sigma-Aldrich, Buchs, Switzerland) at pH 1.5, using bovine
chondroitin 4-sulfate sodium salt from bovine trachea (Fluka,
St. Louis, MO, United States) (Farndale et al., 1986). Total
GAG content of the culture media was also measured to
assess the release of matrix molecules from the constructs.
All samples containing hyaluronan were blanked with media
containing 0.2% hyluronan and DMMB at pH 1.5 was used to
eliminate the noisy signal due to the residual interaction between
DMMB and Hyaluronan.
Histology and Staining
After 28 days of culture, the constructs were fixed in 70%
methanol and 10 µm specimen sections were cut by cryostat,
stained with Safranin O and counterstained with Fast Green
TABLE 2 | Human oligonucleotide primers and probes used for qRT-PCR.
Gene Primer forward (5′–3′) Primer reverse (5′–3′) Probe (5′ FAM-3′ TAMRA)
COL2A1 5′-GGC AAT AGC AGG TTC ACG TAC A-3′ 5′-GAT AAC AGT CTT GCC CCA CTT ACC-3′ 5′-CCT GAA GGA TGG CTG CAC GAA ACA TAC-3′
COL10A1 5′-ACG CTG AAC GAT ACC AAA TG-3′ 5′-TGC TAT ACC TTT ACT CTT TAT
GGT GTA-3′
5′-ACT ACC CAA CAC CAA GAC ACA GTT CTT
CAT TCC-3′
ACAN 5′-AGT CCT CAA GCC TCC TGT ACT CA-3′ 5′-CGG GAA GTG GCG GTA ACA-3′ 5′-CCG GAA TGG AAA CGT GAA TCA GAA TCA
ACT-3′
RunX2 5′-AGC AAG GTT CAA CGA TCT GAG AT-3′ 5′-TTT GTG AAG ACG GTT ATG GTC AA-3′ 5′-TGA AAC TCT TGC CTC GTC CAC TCC G-3′
OC 5′-AAG AGA CCC AGG CGC TAC CT-3′ 5′-AAC TCG TCA CAG TCC GGA TTG-3′ 5′-ATG GCT GGG AGC CCC AGT CCC-3′
RPLP0 5′-TGG GCA AGA ACA CCA TGA TG-3′ 5′-CGG ATA TGA GGC AGC AGT TTC-3′ 5′-AGG GCA CCT GGA AAA CAA CCC AGC-3′
RPLP0, ribosomal protein large P0 housekeeping gene; COL2A1, collagen type 2; COL10A1, collagen type 10; ACAN, aggrecan; RunX2, runt-related transcription factor
2; OC, osteocalcin.
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to detect proteoglycan presence and proteoglycan-depleted,
collagen-rich areas.
Statistical Analysis
The data were produced from three individual experiments, each
carried out with hMSC from a different donor. All experiments
were performed in triplicate, quadruplicate or quintuplicates
for each group at different timepoints in order to reduce
methodological variability. Each measurement was performed
in duplicate. Analyses were done between the appropriate
control group and treatment groups as well as between different
treatment groups, using one way or two ways ANOVA with
Tukey’s Post-hoc testing whenever required. A significance level
of p < 0.05 was applied and data are presented as Mean and
FIGURE 1 | Gene expression measured by qRT-PCR of chondrogenically differentiating hBMSCs-based constructs fed with standard chondropermissive media
(HA-TGF-) supplemented with 0.2% sodium hyaluronate (HA+) or without (HA-) and with 10 ng/ml TGFβ1 (TGFβ+) or without (TGFβ-) and harvested at days 7, 14,
21, and 28. Sodium hyaluronate supplemented in media containing TGFβ1 (HA+ TGF+) supports the chondrogenic gene expression of ACAN and Sox9 and
reduces the upregulation of the hypertrophic cartilage marker collagen type X. Relative quantification of target mRNA was performed according to the comparative
Ct method. Values represent the mean ± SD of three independent hBMSC donors in experimental quadruplicate. Statistical significance was defined as ∗p < 0.05,
∗∗p < 0.01, ∗∗∗p < 0.001, and ∗∗∗∗p < 0.0001.
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STDev. Analyses were carried out using the GraphPadPrism 7
software (GraphPad Software Inc., La Jolla, CA, United States).
RESULTS
Gene Expression Analysis
A panel of genes associated with chondrogenic differentiation
(Collagen type II, Aggrecan, Sox9) were investigated, as well
as Collagen type X associated with hMSCs hypertrophic
differentiation, genes associated with osteogenic differentiation
(RunX2, OC, ALP) and receptors of TGFβ1 (TGFβ_RI,
TGFβ_RII) (Figure 1). To gain further understanding
of the underlying mechanism, the hyaluronan receptor
(CD44) and hyaluronan synthases (HAS1, HAS2, HAS3)
were also investigated.
All donors displayed the same trends to a varying
degree of magnitude. Among the chondrogenic markers,
an overall upregulation of the genes involved in chondrogenic
differentiation was observed when the culture media was
supplemented with TGFβ1.
All media supplemented with TGFβ showed an overall
collagen type II upregulation when compared with TGFβ-free
media. The three media formulations containing TGFβ showed a
similar profile in terms of expression levels and trend among the
different timepoints analyzed. The hypertrophic marker Collagen
type X was significantly upregulated from days 7 to 14, 21,
and 28 in all the constructs fed with standard chondrogenic
media (HA-TGFβ+) with a significant peak at day 21. However,
when Hyaluronan is added to the culture media (HA+ TGF+)
there is an overall reduction of collagen 10 upregulation at all
timepoints. In the second and the last week of chondrogenesis
there was no significant increase of collagen 10 compared with
day 7. As with HA into the media (HA+ TGFβ+), HA inside
the scaffold (HASc TGFβ+) also contributes to reducing the
upregulation of the collagen 10 at days 21 and 28 when compared
with standard chondrogenic media (HA-TGFβ+). However, the
HASc TGF+ group showed a significantly higher Collagen 10
expression from days 7 to 14 compared with HA+ TGF+ group.
All TGFβ supplemented media showed a similar profile with
a higher COL2A1/COL10A1 ratio compared with TGFβ depleted
media. However, among the TGFβ1 supplemented media, only
the group where HA was added (HA+ TGFβ+), showed a
significant and progressive increase of the COL2/Col10 ratio
from days 7, 14, and 21 to 28. Indeed, for HA depleted media
(HA-TGF+), the ratio appears to reach a peak at day 21 although
no further significant increase of the ratio was observed from
days 21 to 28. When HA was added inside the scaffold (HASc
TGF+ group) the COL2A1/COL10A1 ratio reached a peak
at day 21 and significantly contributed to an increased ratio
from days 7 to 28.
As observed for collagen type II, aggrecan upregulation
was observed upon TGFβ supplementation. However, further
addition of hyaluronan led to statistically significant increases
(Figure 1). Only the groups where hyaluronan was present in
the culture media (HA+ TGF+) or added inside the scaffold
(HASc TGF+) showed a significant upregulation of aggrecan
gene expression from days 7 to 21 in both groups and from day 7
to 14 in the HASc group.
The expression of ACAN at day 14 in HASc TGF+ group
was significantly higher compared to the media TGFβ depleted
at the same timepoint.
Sox9 expression in the three TGFβ-supplemented media
was similar and higher than TGFβ-free media. However,
only in groups containing HA do the differences become
significant (Figure 1).
In the HASc TGF+ group Sox9 was upregulated earlier at day
14 when it reaches the peak.
The Sox9/Runx2 ratio behaved similarly to the COL2/10
ratio and showed an overall upregulation when the media is
supplemented with TGFβ. Particularly, standard chondrogenic
media (HA-TGFβ+) showed a significant increase of the ratio
from days 7 to 21 and 28. HA supplemented chondrogenic media
(HA+ TGF+), also significantly increased the Sox9/RunX2 ratio
from days 7 to 21 and 28. In addition, the average value observed
in HA+ TGF+ group at day 28, although not significantly
different from day 21, showed a tendency to increase compared
with day 21, contrary to that seen in the other two TGFβ
supplemented groups.
HASc TGF+ group showed a similar profile of HA-
TGF+ group with a significant increase of the ratio from days
7 to 21, but not from days 7 to 28.
TGFβRI and II appear to respond in the opposite way to
TGFβ supplementation. When the media is TGFβ supplemented,
the TGFβRI is more expressed compared with TGF free media
groups. Contrarily TGFβRII appear to be slightly less expressed
when media is supplemented with TGF compared to TGF free
media groups. These observations did not reach significance so
the data is not shown.
None of the osteogenic markers (RunX2, ALP, OC), were
affected by TGFβ or HA supplementation (data not shown).
The expression of HAS 1, 2, and 3 was also largely unaffected
by media supplementation (data not shown). CD44 was slightly
downregulated over time in all the groups. However, despite a
similar trend, no significant downregulation was observed upon
media supplementation (data not shown).
Sulfated Glycosaminoglycan and DNA
Quantification
After 4 weeks in culture, no significant differences were
observed in DNA content among different groups compared
with the control (Figure 2). An overall significant increase in
sulfated GAG per scaffold/DNA ratio was observed when the
medium was supplemented with TGFβ. We also investigated
the sGAG and DNA content. After 28 days of chondrogenesis
the GAG/DNA ratio per scaffold (Figure 2B) showed a similar
GAG deposition in all the media supplemented with TGFβ1,
which was significantly higher if compared with the control
media (HA-TGF-) and with the hMwt HA supplemented media
(HA+ TGF-). However, as it has been shown that part of
the sGAG produced within the polyurethane: fibrin scaffold
used in this study, are released into the culture media (Wu
et al., 2017), the sGAG/DNA ratio per scaffold does not
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FIGURE 2 | Biochemical analysis of chondrogenically differentiated constructs after 4 weeks in culture shows a significantly higher GAG/DNA when hyaluronic acid is
supplemented in culture media (HA+ TGF-). (A) Bisbenzimide Höchst 33528 dye was used to quantify the DNA in proteinase K digests of scaffolds.
Dimethylmethylene blue (DMMB) at pH 1.5 was used to determine the total amount of sulfated glycosaminoglycan (GAG) produced by mesenchymal stem cells
(MSCs). The GAG/DNA ratio was calculated from total DNA and GAG values to show the production of GAG relative to the MSCs present in each group from the
proteinase K construct digests (B) and the collected culture media (C). All culture media samples containing HA were blanked with media containing HA. Values
represent the mean ± SD of three independent hBMSC donors in experimental triplicate or quadruplicate. Statistical significance was defined as *p < 0.05, and
**p < 0.01.
reflect the total amount of sGAG produced by the hMSCs.
For this reason, the sGAG/DNA per media was investigated
and surprisingly the HA+ TGF- group free from the growth
factor TGFβ1, produced significantly higher sGAG/DNA after
28 days of chondrogenesis when compared with the control
media HA-TGF- (Figure 2C).
Media GAG showed an overall significant increase in all the
experimental groups compared with the control group (HA-
TGF-). Particularly, the HA supplemented chondropermissive
media TGFβ free (HA+ TGF-), showed a significantly higher
media GAG compared with the control group. Also, HA
inside the constructs (HASTGF+) were significantly higher
than the control.
With HA containing media (mainly HA+ TGF- and
less markedly HA+ TGF+) a significant amount of sGAG
was produced by the hMSCs and released into the culture
media within the first week (Figures 3, 4). Within the
first week of chondrogenesis, the level of GAG in the
media supplemented with HA alone (HA+ TGFβ-) was
significantly and consistently higher among all three donors
when compared with the control TGFβ free medium (HA-
TGFβ-) and the standard chondrogenic media containing
active TGFβ (HA- TGFβ+) (∗∗p < 0.01; ∗p < 0.05)
(Figures 3, 4). Particularly, after 2 days of chondrogenic
culture, the chondropermissive media supplemented with
HA (HA+ TGF-) had significantly higher (p < 0.01) GAG
release when compared with the standard chondropermissive
media (HA-TGFβ-), with the standard chondrogenic media
(HA-TGFβ+) (p < 0.01) and with the HASTGFβ+ group
(p < 0.05). The sGAG/DNA of the HA+ TGF- group
was comparable with all the other groups fed with TGFβ1
containing media.
At the same timepoint, the GAG level of the standard
chondrogenic media HA-supplemented (HA+ TGFβ+)
was also significantly higher compared to the control
chondropermissive media (HA-TGFβ-) and to the chondrogenic
media (HA-TGFβ+).
On day 4, HA+ TGFβ- continued to be significantly higher
if compared to HA-TGFβ+ and by day 7, the average value of
HA+ TGFβ- continued to be higher than HA-TGFβ+.
However, hyaluronan supplemented chondropermissive
media (HA+ TGFβ-) continued to be significantly different from
the chondropermissive media control (HA-TGFβ-) until day 18
of chondrogenic culture.
After 14 days of chondrogenesis, the GAG media content of
the HA+ TGFβ+ group was greater than the HA+ TGFβ- group
and it continued to increase over time until day 28.
By day 16, the GAG released by the HASTGFβ+ group slightly
exceeded the average value of all other groups and at the same
timepoint became significantly higher than the HA-TGFβ- group,
continuing to increase until the end of chondrogenic culture.
Histology and Safranin O/Fast Green
Staining
In order to show the deposition of sulfated GAGs, after
28 days of chondrogenesis the differentiated constructs were
stained with Safranin O and counterstained with Fast green
(Figures 5A–N). Positive Safranin O staining was present along
the upper and lateral surface of the constructs when the media
was supplemented with TGFβ alone (HA-TGF+) and with both
factors (HA+ TGF+) with the exception of donor 1 where a
slight Safranin O staining was observed only when the media was
supplemented with both HA and TGFβ factors (HA+ TGF+).
Stronger positive staining was present in the same region
of the constructs when hyaluronan was added directly into
fibrin embedding the scaffolds fed with standard chondrogenic
media (HASc TGFβ+ group). No staining was observed in the
constructs fed with TGFβ1 free media.
DISCUSSION
Chondrogenic differentiation of mesenchymal stem/stromal cells
is routinely evaluated using either monolayer, pellet culture
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FIGURE 3 | GAG produced and released into culture media from chondrogenically differentiated hBMSC-based constructs over 4 weeks in culture.
Chondropermissive medium supplemented with 0.2% sodium hyaluronate (HA+ TGF-) significantly increase sulfated GAG production detected in culture media in
the early days of the hBMSC chondrogenesis in the absence of TGFβ. HA supplemented in standard chondrogenic media (HA+ TGF+) did also lead to significant
increase in sulfated GAG. sGAG content in culture medium was determined spectrophotometrically following reaction with 1.9-dimethylmethylene blue (DMMB) pH
1.5. All samples containing HA were blanked with medium containing HA. Values represent the mean ± SD of three independent hBMSC donors in experimental
quadruplicate or quintuplicate. Statistical significance was defined as *p < 0.05, and **p < 0.01.
in presence of TGFβ1, or three-dimensional fibrin matrices
and insulin-like growth factor-1 (Johnstone et al., 1998; Yoo
et al., 1998; Worster et al., 2000, 2001). Thus, most of the
in vitro culture models to investigate cartilage repair therapies
are highly simplified and critical in vivo signals that can
potentially change the chondrogenic behavior of hBMSCs
are lacking.
Particularly relevant in vivo functions come from synovial
fluid, including acting as a shock absorber and friction reducer,
supply of oxygen, nutrients and removal of metabolic waste and
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 8 March 2020 | Volume 8 | Article 243
fbioe-08-00243 March 27, 2020 Time: 17:40 # 9
Monaco et al. HA Enhanced Chondrogeneis
FIGURE 4 | Cumulative sGAG produced and released into culture media from chondrogenically differentiated hBMSC-based constructs along 4 weeks in culture.
FIGURE 5 | Differentiated constructs stained with safranin O and counterstained with Fast Green after 4 weeks of chondrogenic culture. Images showing higher
magnification of the right upper side and the full section of the constructs for three independent hBMSC donors. The HASc TGF+ group shows the best matrix
deposition. Scale bar full section: 200 µm, scale bar overview images: 2 mm. Images (A–C) show the control group fed with chondropermissive media (HA-TGF–);
Images (D–F) show the constructs fed with chondropermissive media supplemented with HA (HA+ TGF-); Images (G–I) show the constructs fed with chondrogenic
media (HA-TGF+); Images (J–L) show the constructs fed with chondrogenic media supplemented with HA (HA+ TGF+); Images (M,N) show the constructs
containing HA and fed with chondrogenic media (HASc TGF+).
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FIGURE 6 | Representative schema of the study experimental steps and design.
CO2 from articular chondrocytes (Davies, 1966; Tamer, 2013).
Some of these functions are reproduced in in vitro models by the
cell culture media. However, synovial fluid is known to contain
hMwt HA, which to date has been absent from the majority of
culture media used in in vitro culture systems. This limits the
efficacy and reliability of in vitro tests, placing a higher burden
on in vivo models.
To be one step closer to synovial fluid composition, the
present study investigated the effect of a chondrogenic media
supplemented with a physiological concentration of exogenous
hMwt HA, on the differentiation of hBMSCs in a 3D environment
(Figure 6). In the present study a pharmaceutical grade HA
was used with very low endotoxin contamination (≤0.02 eu/mg
or ≤0.05 eu/mg).
Our findings show that monolayer expanded hBMSCs
when fed with chondropermissive media supplemented with
hMwt HA alone or combined with TGFβ1 undergo, within
28 days, chondrogenic differentiation in 3D microporous
polyurethane:fibrin culture system.
Particularly, upon the addition of hMwt HA to
chondropermissive medium, we observed: (1) a reduced
upregulation of the hypertrophic marker collagen type X, as
well as a positive effect on Sox9 and ACAN gene expression
level in culture media further supplemented with TGFβ1, (2) a
significantly higher sGAG production and release in the culture
media within the first week of chondrogenesis and especially in
the first 48 h, (3) a more marked extracellular matrix deposition
when hMwt HA was supplemented inside the scaffold, (4)
consistent and reproducible trends in three different hMSC
donors over 28 days of chondrogenic culture.
hMwt HA Reduces the Expression of
Collagen Type X in TGFβ1 Containing
Media
Several studies proposed a beneficial effect of hMwt HA
in tissue repair following injury or inflammation and the
potential role of hyaluronic acid on the differentiation of hMSCs
(Shinomura and Kimata, 1990; Jiang et al., 2007; Salamanna
et al., 2019). Hypertrophy is one of the main problems related
with MSC differentiation in exogenous TGF-β containing media
(Johnstone et al., 1998; Goldring et al., 2006). As a result,
new protocols to prevent hypertrophy need to be developed to
address a stable chondrogenic phenotype, which will help to
enable the use of MSCs in clinics. Exogenous hyaluronan, in
combination with anti-inflammatory signals, has been shown
to act as disease modifying drugs following intra articular
delivery with anti-hypertrophic and pro-chondrogenic effects
(Prasadam et al., 2013). Similar results were observed when
hyaluronic acid was added in a composite 3D collagen gel
to address in vitro chondrogenesis of human adipose-derived
mesenchymal stem cells in co-culture with human chondrocytes.
The reduced upregulation of collagen type X appeared to be
dose dependent with the best collagen type X reduction at 5%
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HA (Amann et al., 2017). A reduction of peri-chondrocyte type
X collagen was also observed following intraarticular injection of
allogeneic MSCs in combination with hyaluronic acid in rabbits
(Chiang et al., 2016). The present study confirms the previous
findings since the addition of hMwt HA to the chondrogenic
media containing TGFβ1 (HA+ TGF+) reproducibly reduced
the upregulation of the hypertrophic marker collagen X after
28 days of chondrogenesis. HA inside the scaffold (HASc TGF+)
also contributed to reducing the upregulation of collagen type
X compared with HA-TGF+, but less markedly than hyaluronic
acid supplemented media (HA+ TGF+).
In addition to the reduced upregulation of collagen type X,
previous studies have shown an enhanced expression of the
chondrogenic markers Sox9 and aggrecan when hMSCs were
cultured on hyaluronic acid-coated dishes and the media was
supplemented with TGFβ3 (Bhang et al., 2011). The enhanced
chondrogenic differentiation of hMSCs due to the interactions
with both a specific cell-adhesion matrix as hyaluronic acid and
a soluble growth factor as TGFβ3 was shown to be additive
(Bhang et al., 2011). The beneficial effect of hyaluronic acid on the
upregulation of Sox9 expression was also highlighted in another
study conducted by Amann et al. using 1% hyaluronic acid in
a 3D collagen hydrogel (Wu et al., 2010; Amann et al., 2017).
In the present work we also observed a beneficial effect of the
hMwt HA in combination with TGFβ1, on the expression of
human chondrogenic markers Sox9 and ACAN. Particularly we
observed a statistically significant improvement of the expression
level of both genes between days 7 and 21 in media supplemented
with both TGFβ1 and hyaluronic acid. HA inside the scaffold
significantly upregulated ACAN but did not contribute to a
significant upregulation of Sox9 and collagen II, showing a
similar profile to the other TGFβ containing media groups.
Upon the addition of hMwt HA, we did not observe a
significant upregulation of collagen type II. However, the collagen
type II/X mRNA ratio, a chondrocyte differentiation marker, was
significantly upregulated over 28 days. A similar upregulation
was also present for the HA-TGF+ group but in this case no
significant upregulation was observed between days 21 and 28
due to a peak at day 21. This peak was always present for
collagen type II, X, and II/X ratio in the HA-TGF+ group. The
addition of HA in the culture media appears to attenuate this
peak and this attenuation was particularly evident for collagen
type X and the II/X ratio. This attenuation could be beneficial
for the reduction of unwanted hMSC hypertrophy, which in
the standard culture media (HA-TGF+) seems to be particularly
pronounced at day 21.
In the present study, CD44 (a cell surface HA receptor;
Aruffo et al., 1990) gene expression was unaffected suggesting
the possible absence of interaction between exogenous HA and
the receptor. This lack of interaction could be due to the
high molecular weight of HA used in the present study (1,000
and 1,800 KDa). Several studies reports that low molecular
weight fragments (50 KDa) derived from HA degradation bind
and activate CD44 receptors during inflammation, promoting
cytokine expression (Campo et al., 2009, 2012). However, high
molecular weight HA (1,000–7,000 KDa) does not bind CD44
and therefore, does not activate biochemical mediators of damage
(Campo et al., 2009; Avenoso et al., 2018). Thus, the lack of
upregulation of CD44 indirectly suggests that the hMwt HA did
not degrade over time.
hMwt HA-Supplemented Media Induces
a Significant Increase of Early sGAG
Synthesis
Chondrocytes embedded in a collagen gel, showed an enhanced
sGAG synthesis as well as chondrocyte proliferation after
treatment with 0.1 mg/ml 800 KDa HA (Kawasaki et al., 1999).
Akmal et al. (2005) partly confirmed the results of the previous
study and showed that HA supplemented culture media in
the range between 0.1 and 1 mg/ml enhanced chondrocyte
metabolic activity and DNA synthesis, facilitating the deposition
of GAG in cartilage tissue between days 9 and 14. Amann
et al. (2017) found a significant increase in sGAG production
by adipose mesenchymal stem cells seeded in a collagen gel
supplemented with different concentrations of HA, with the
best GAG/DNA ratio observed with 1% 1.5–1.8 MDa HA. Wu
et al. (2017) supplemented the culture media with different
concentrations of 1.8 MDa HA and, differently from the previous
studies, observed that 2 mg/ml promoted a better preservation
of chondrocyte phenotype under joint-kinematic-mimicking
treatment especially in terms of collagen type II/I ratio.
None of the studies described above investigated the effect
of continuous exposure to hMwt HA supplemented culture
media on the chondrogenic differentiation behavior of human
bone marrow derived MSCs over 28 days. This could also
explain why, in the present work, under static conditions
we observed an improvement of the chondrogenic phenotype
and an attenuation of the hMSC hypertrophic differentiation
following a longer and more constant exposure of the developing
constructs to hMwt HA.
In the present work two different types of hyaluronic acid
were used: a 1,800 kDa HA was supplemented at 2 mg/ml in the
culture media and 1,000 kDa HA was added inside the fibrin gel
at 0.2 mg/ml. 1,800 kDa is closer to the size found in synovial
fluid, whereas 1,000 kDa was used in the scaffold due to its
ease of handling and mixing with the fibrin. Differently from
the previous work, in our study we didn’t observe proliferation
since the hMSCs DNA content did not increase from days 0
to 28 following the addition of hMwt HA. This might suggest
that hMSCs seeded in the polyurethane:fibrin composite were
more committed toward chondrogenic differentiation rather
than proliferation and hMwt HA did not affect this behavior.
It is also necessary to consider that the studies previously
described used mainly chondrocytes and not MSCs. Thus, we
can assume that the commitment level of the cell type affects
the response to hyaluronic acid and based on previous studies,
chondrocytes are more inclined to proliferation than MSCs
which, in our study, appeared to be more prone to differentiation
with the proper stimuli.
The reasons for the early GAG production and release into
the media are unclear but previous studies have shown that
hyaluronic acid promoted a chondroprotective effect following
intra articular injection in vivo, with an increase of the
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endogenous proteoglycan and glycosaminoglycan synthesis and
a suppression of the degradation (Kobayashi et al., 2004;
Altman et al., 2015). HA promoted the mobilization of the
newly synthesized proteoglycan from the pericellular matrix
to the interterritorial cartilage matrix, providing protection
against degradation and contributing to the strengthening of the
interterritorial cartilage matrix (Kikuchi et al., 2001; Altman et al.,
2015). This mobilization could have happened also in our system
but due to the early sGAG production, we could hypothesize that
there is insufficient pericellular ECM to be able to retain the newly
produced ECM causing its release into the media.
The early GAG production might also be explained by
another interesting phenomena: macromolecular crowding.
Macromolecular crowding (MMC), a biophysical phenomenon
known to accelerate in vitro biological processes, accelerate and
increases ECM deposition (Minton, 2001; Kumar et al., 2015;
Shendi et al., 2019). The crowded environment is achieved
by supplementation of the culture media with a synthetic or
natural macromolecule (Kumar et al., 2015). Thanks to the
excluded volume effect exerted by the macromolecule, the culture
media better recapitulates the crowded physiological in vivo
environment and this is the reason of the in vitro acceleration
of biological processes as ECM deposition (Kumar et al., 2015;
Prewitz et al., 2015). Previous studies suggested that MMC can
enhance GAG deposition during hMSC differentiation (Welter
et al., 2009; Prewitz et al., 2015) and have shown culture
media supplemented with 0.2% 1.8 MDa hyaluronic acid acts
as macromolecular crowding agent (Zhou et al., 2008; Shendi
et al., 2019). Therefore, the early sGAG production observed
within the first week of chondrogenesis and particularly within
the first 48 h of culture, could be explained by a potential
macromolecular crowding effect exerted by hyaluronic acid
supplemented in culture media. However, we did not observe an
increased expression of collagen type I, II, III, or aggrecan.
hMwt HA in Fibrin Gel Enhances the
ECM Deposition
Histological analysis of ECM deposition provided evidence of
positive Safranin O staining when the media was supplemented
with TGFβ1. Addition of HA in the culture media slightly
improved the ECM deposition. However, when HA was added
inside the scaffold a stronger ECM deposition was observed.
Simple mixing of HA to a fibrin composite as performed here
would be a clinically applicable carrier gel that could be used to
deliver MSCs locally into a cartilage defect. Our results indicate
this would be beneficial when considering matrix deposition.
In a previous study it was observed that HA inside a hydrogel
might affect cell behavior as it reduces oxygen concentration
(Amann et al., 2017). Several studies suggest that low oxygen is
favorable for chondrocyte phenotype maintenance and could be
used as stimulus for hMSC chondrogenic differentiation (Buckley
et al., 2010; Sheehy et al., 2012).
Exogenous hyaluronic acid injected into rabbit knee joints was
incorporated into articular cartilage (Antonas et al., 1973). This
incorporation could happen also over time in our system when
the differentiating hMSCs are in contact with exogenous HA
supplemented directly in the fibrin gel or in the culture media.
HA supplemented in media or in the fibrin gel might facilitate
the accumulation of extracellular matrix since HA is one of the
main components, thus explaining the better extracellular matrix
deposition in HASc TGF+ group.
In addition, the gene expression results of Sox9, ACAN and
collagen type 10, the sGAG deposition and the histological
analysis, suggests that the location of hyaluronic acid might
play a role on the chondrogenic response of hMSCs seeded
inside a 3D scaffold.
Despite mesenchymal stem cells holding great promise
for the treatment of orthopedic injury and disease, donor
variation during chondrogenic differentiation has severely
hindered their clinical use (Kim et al., 2018). Donor variation
makes interpretation of the results more difficult and often,
when statistical analysis is performed on several donors, some
useful results can be hidden. In these cases, it is better to
aim at personalized medicine and to study the behavior of
individual donors.
In the present study, despite the small donor variation
observed, the trends of gene expression analysis, sGAG
production and deposition, and histological analysis was
consistent, reliable and reproducible among three different
human mesenchymal stem cell donors.
CLINICAL SIGNIFICANCE AND
POTENTIAL APPLICATIONS
In vitro models aim to recapitulate the complexity of in vivo
systems. Most of the work on chondrogenic differentiation of
hMSCs use a culture media with a very simple composition
which is an oversimplification of the in vivo system. In order
to mimic more closely the in vivo physiology, current models
need to be improved to reflect the complexity of the synovial
joint environment and to try to more accurately predict in vivo
outcomes. In the current climate of animal welfare and “3Rs,”
more accurate in vitro models will be crucial to prevent in vitro
artifacts and to enable more accurate prescreening of potential
cartilage repair therapies. Producing reliable results in vitro
that are more representative of the in vivo outcome, will
also help to reduce the need for animal studies. Therefore,
in addition to the standard approaches that aim to engineer
cartilage tissue, it is worth to pursue the bioengineering of a
more complex culture media. In addition, the association of
HA media with human mesenchymal stem cells and fibrin gel,
which is currently used in clinical practice, makes the whole
system more relevant for clinics. HA supplemented media,
being one step closer to the synovial fluid, can be used to
make preclinical testing systems more predictable of clinics for
several applications:
(1) to screen and evaluate potential cartilage and
osteochondral repair therapies which involves the use
of human MSCs (differentiating cartilage) or human
chondrocytes (mature cartilage) in in vitro models or
ex vivo systems simulating traumatic defects or diseases,
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(2) to screen new biomaterials designed for tissue engineering
and clinical application purposes,
(3) to screen new drug candidates for cartilage regeneration
and osteochondral repair,
(4) to study the behavior of autologous or allogeneic human
stem cell for intra articular joint injection in 2D/3D in vitro
environments,
(5) to potentially increase the clinical effectiveness of tissue
engineered constructs developed in a more synovial fluid-
like environment.
CONCLUSION AND PERSPECTIVES
Overall, our results demonstrate that the constant
supplementation of 1.8 MDa hMwt HA at 2 mg/ml to the
culture media or the addition of 1 MDa hMwt HA into the
scaffolds at 0.2 mg/ml, had a positive effect on the intrinsic
capacity of hMSCs to produce ECM. Increased sGAG production
occurred especially in the early days of chondrogenesis when
the hMwt HA was supplemented in culture media; while a
better matrix deposition was observed when hMwt HA was
added in the scaffold. Considering all the evidence mentioned
above, further studies are ongoing to investigate the composition
of the ECM released into the culture media and deposited
inside the constructs.
First it would be interesting to understand the underlying
mechanism by which the addition of HA into the media
leads to an increased early production and why this effect
decreases with time in culture. Finding these answers would
allow a better understanding how to prevent the release of
the sGAG and this would help to rapidly establish an initial
ECM pericellular matrix. This would function as an improved
baseline to assist in the effective deposition of further ECM
that might contribute to a final improved/stronger ECM
quality and quantity.
Eventually, physicochemical culture media factors that affect
the cellular response and matrix deposition, such as viscosity
(Laurent and Ogston, 1963; Laurent, 1995), osmolality (Laurent
and Ogston, 1963; Urban et al., 1993; Palmer et al., 2001),
diffusion properties (Hansen et al., 2016), and the potential
interaction between HA and other molecules in the culture media
(Kuznetsova et al., 2015), should be further investigated.
At the gene expression level, exogenous hMwt HA reduced the
upregulation of the hypertrophic cartilage marker collagen type
X. Therefore, a more stable hMSC chondrogenic differentiation
can also be achieved through the development of a more
physiological synovial-like bioengineered culture media. The
bioengineered media might also reproduce in vitro another
important function exerted by hMwt HA in vivo, namely
its function as a shock absorber and friction reducer during
dynamic loading. It is an ideal lubricant in the synovial joints
due to its shear-dependent viscosity (Laurent et al., 1996;
Morgese et al., 2018). Sliding motion and dynamic compression
induces hMSCs chondrogenesis (Schatti et al., 2011) and joint-
kinematic-mimicking mechanical loading combined with HA
media improves matrix production in a bovine chondrocyte
cartilage engineered model (Wu et al., 2017). In addition,
specific stimuli mimicking human articular joint kinematics
may promote the development of a functional articular surface–
synovial interface (Grad et al., 2005). For these reasons it will be
of high interest to perform additional studies in this direction to
further increase the complexity by including mechanical stimuli
typically experienced within articular joints. This will be possible
thanks to our joint-simulating bioreactor that mimics the knee
joint kinematics (Wimmer et al., 2004; Schatti et al., 2011). Thus,
future work will include long-term loading experiments over
several weeks to investigate if the lubricating capability of HA
supplemented media can act synergistically with joint kinematic
motion to address the chondrogenic differentiation behavior
of hMSCs. This study will be useful on experimental level to
improve our understanding of the homeostasis mechanisms
of articulating joints and on a clinical level might serve as
baseline to improve knee joint rehabilitation protocols after
trauma or disease.
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